Adeno-associated viruses from primates & derived vectors (updated 2024) [PDF, 392KB]
Adenovirus-based vaccine strain Ad26.COVS1 (J&J, 2020) [PDF, 498KB]
Adenovirus-based vaccine strain Ad26.ZEBOV (Zabdeno, 2021) [PDF, 493KB]
Adenovirus-based vaccine strain ChAdOx1 nCoV-19 (AstraZeneca, 2020) [PDF, 510KB]
Adenovirus-based vaccine strains rAd5-S-CoV2 & rAD26-S-CoV2 (SputnikV, 2021) [PDF, 490KB]
Adenoviruses from primates_gene transfer with (updated 2021) [PDF, 608KB]
RNA viruses: minigenomes, replicons & virus-like particles (2021) [PDF, 639KB]
Current classifications
Statements on safety-related issues in genetic engineering work or facilities
The ZKBS adopts general recommendations (position statements) on safety-relevant issues that often occur in genetic engineering operations or in genetic engineering facilities. Such general recommendations relate in particular to the risk assessment of organism, the containment level assignment of genetic engineering work or the assessment of safety-related measurements.